UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV

PloS one, 2022-02, Vol.17 (2), p.e0262917

2022

Link zum Volltext

Verfügbarkeit prüfen

Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models

Scientific reports, 2022-11, Vol.12 (1), p.18575-18575, Article 18575

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy

Infection, 2020-08, Vol.48 (4), p.553-558

2020

Link zum Volltext

Verfügbarkeit prüfen

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients

PloS one, 2017-07, Vol.12 (7), p.e0181890-e0181890

2017

Link zum Volltext

Verfügbarkeit prüfen

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype

World journal of gastroenterology : WJG, 2016-10, Vol.22 (38), p.8509-8518

2016

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated With Resolution or Chronicity

Journal of acquired immune deficiency syndromes (1999), 2019-10, Vol.82 (2), p.175

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

European journal of epidemiology, 2012-08, Vol.27 (8), p.657-665

2012

Link zum Volltext

Verfügbarkeit prüfen

Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)–Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including Ribavirin

Clinical infectious diseases, 2016-02, Vol.62 (4), p.527-528

2016

Link zum Volltext

Verfügbarkeit prüfen

Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals

Journal of hepatology, 2017-08, Vol.67 (2), p.415-417

2017

Link zum Volltext

Verfügbarkeit prüfen

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir

Medicine (Baltimore), 2016-05, Vol.95 (22), p.e3780

2016

Link zum Volltext

Verfügbarkeit prüfen

Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

International journal of infectious diseases, 2023-04, Vol.129, p.266-273

2023

Link zum Volltext

Verfügbarkeit prüfen

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

BMC infectious diseases, 2017-01, Vol.17 (1), p.43-43, Article 43

2017

Link zum Volltext

Verfügbarkeit prüfen

Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies

International journal of cancer, 2012-06, Vol.130 (12), p.2990-2996

2012

Link zum Volltext

Verfügbarkeit prüfen

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

AIDS (London), 2010-03, Vol.24 (6), p.924-928

2010

Link zum Volltext

Verfügbarkeit prüfen

Immortal time bias: authors' reply

AIDS (London), 2015-04, Vol.29 (7), p.860-861

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical, Virologic, and Immunologic Outcomes in Lymphoma Survivors and in Cancer-Free, HIV-1―Infected Patients: A Matched Cohort Study

Cancer, 2013-08, Vol.119 (15), p.2710-2719

2013

Link zum Volltext

Verfügbarkeit prüfen

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply

AIDS (London), 2015-04, Vol.29 (7), p.857-859

2015

Link zum Volltext

Verfügbarkeit prüfen

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

Journal of antimicrobial chemotherapy, 2012-01, Vol.67 (1), p.213-217

2012

Link zum Volltext

Verfügbarkeit prüfen

Mortality of HIV―infected patients with or without cancer: comparison with the general population in Italy

Antiviral therapy, 2012-01, Vol.17 (3), p.447-458

2012

Link zum Volltext

Verfügbarkeit prüfen

Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine

Journal of acquired immune deficiency syndromes (1999), 2011-04, Vol.56 (4), p.e113

2011

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs

Liver international, 2013-08, Vol.33 (7), p.1113-1120

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

AIDS (London), 2012-09, Vol.26 (14), p.1837-1840

2012

Link zum Volltext

Verfügbarkeit prüfen

Optimal dietary calcium intake in HIV treated patients: No femoral osteoporosis but higher cardiovascular risk

Clinical nutrition (Edinburgh, Scotland), 2014-04, Vol.33 (2), p.363-366

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

AIDS (London), 2009-09, Vol.23 (15), p.2029-2037

2009

Link zum Volltext

Verfügbarkeit prüfen

Immune recovery and T cell subset analysis during effective treatment with maraviroc

Journal of antimicrobial chemotherapy, 2012-10, Vol.67 (10), p.2474-2478

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Humans
(39)
Science & Technology
(39)
Life Sciences & Biomedicine
(36)
Female
(30)
Male
(29)
Infectious Diseases
(25)
Adult
(24)
Hiv Infections - Drug Therapy
(22)
Middle Aged
(22)
Human Immunodeficiency Virus
(16)
Immunology
(16)
Biological And Medical Sciences
(15)
Hiv
(15)
Medical Sciences
(15)
Aids/hiv
(14)
Hiv Infections - Complications
(13)
Human Viral Diseases
(12)
Viral Diseases
(12)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(12)
Retrospective Studies
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV

Modelling the impact of protein-kinase R allelic variant on HIV biomarkers trajectories by means of latent class mixed models

HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy

Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients

TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype

Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated With Resolution or Chronicity

Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy

Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)–Coinfected Patients With Advanced Liver Disease During Anti-HCV Treatment With Direct-Acting Antiviral Regimens Including Ribavirin

Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir

Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience

Immortal time bias: authors' reply

Clinical, Virologic, and Immunologic Outcomes in Lymphoma Survivors and in Cancer-Free, HIV-1―Infected Patients: A Matched Cohort Study

Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors' reply

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

Mortality of HIV―infected patients with or without cancer: comparison with the general population in Italy

Durability and safety of a novel salvage therapy in R5-tropic HIV-infected patients: maraviroc, raltegravir, etravirine

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs

Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens

Optimal dietary calcium intake in HIV treated patients: No femoral osteoporosis but higher cardiovascular risk

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

Immune recovery and T cell subset analysis during effective treatment with maraviroc

Aktive Filter

Suchergebnisse filtern